Sandra E. Chaudron

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Pretreatment Resistance to Integrase Inhibitors in the Swiss HIV Cohort Study From 1995 to 2025.

Pretreatment Resistance to Integrase Inhibitors in the Swiss HIV Cohort Study From 1995 to 2025.

Journal: Open forum infectious diseases

Published: April 07, 2026

Acceptance and preferences for different nicotine substitute products to reduce tobacco smoking in people living with HIV: Results from an internal pilot study of a randomized trial.

Acceptance and preferences for different nicotine substitute products to reduce tobacco smoking in people living with HIV: Results from an internal pilot study of a randomized trial.

Journal: Tobacco induced diseases

Published: December 15, 2025

Corrigendum to 'Implementing a randomization consent to enable Trials within Cohorts in the Swiss HIV Cohort Study - A mixed-methods study' [Journal of Clinical Epidemiology, 188 (2025) 111973].

Corrigendum to 'Implementing a randomization consent to enable Trials within Cohorts in the Swiss HIV Cohort Study - A mixed-methods study' [Journal of Clinical Epidemiology, 188 (2025) 111973].

Journal: Journal of clinical epidemiology

Published: November 21, 2025

Offer of a menu of different nicotine substitute products to REduce Tobacco Use iN pEople living with HIV (RETUNE): a protocol for a pragmatic randomized trial within the Swiss HIV Cohort Study.

Offer of a menu of different nicotine substitute products to REduce Tobacco Use iN pEople living with HIV (RETUNE): a protocol for a pragmatic randomized trial within the Swiss HIV Cohort Study.

Journal: Trials

Published: July 05, 2025

Implementing a randomization consent to enable Trials within Cohorts in the Swiss HIV Cohort Study - A mixed-methods study.

Implementing a randomization consent to enable Trials within Cohorts in the Swiss HIV Cohort Study - A mixed-methods study.

Journal: Journal of clinical epidemiology

Published: May 12, 2025

Safety of Bacillus Calmette-Guérin Vaccination and Impact on HIV-1 Latent Reservoir Size in People With Treated HIV-1 Infection.

Safety of Bacillus Calmette-Guérin Vaccination and Impact on HIV-1 Latent Reservoir Size in People With Treated HIV-1 Infection.

Journal: Open forum infectious diseases

Published: April 21, 2025

Distinct neutralization sensitivity between adult and infant transmitted/founder HIV-1 subtype C viruses to broadly neutralizing monoclonal antibodies.

Distinct neutralization sensitivity between adult and infant transmitted/founder HIV-1 subtype C viruses to broadly neutralizing monoclonal antibodies.

Journal: PLoS pathogens

Published: January 29, 2025

Estimates of HIV-1 within-host recombination rates across the whole genome.

Estimates of HIV-1 within-host recombination rates across the whole genome.

Journal: Virus evolution

Published: January 05, 2025

Addressing data management and analysis challenges in viral genomics: The Swiss HIV cohort study viral next generation sequencing database.

Addressing data management and analysis challenges in viral genomics: The Swiss HIV cohort study viral next generation sequencing database.

Journal: PLOS digital health

Published: August 21, 2024

Absence of Proviral Human Immunodeficiency Virus (HIV) Type 1 Evolution in Early-Treated Individuals With HIV Switching to Dolutegravir Monotherapy During 48 Weeks.

Absence of Proviral Human Immunodeficiency Virus (HIV) Type 1 Evolution in Early-Treated Individuals With HIV Switching to Dolutegravir Monotherapy During 48 Weeks.

Journal: The Journal of infectious diseases

Published: May 05, 2023

The Interplay Between Replication Capacity of HIV-1 and Surrogate Markers of Disease.

The Interplay Between Replication Capacity of HIV-1 and Surrogate Markers of Disease.

Journal: The Journal of infectious diseases

Published: January 05, 2022

A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort Study.

A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort Study.

Journal: The Journal of infectious diseases

Published: December 10, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026